Microbot Medical Inc.

MBOT ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $3.9M $3.1M $2.5M $2.4M $13.5M $19.7M $28.8M $5.2M
Accounts Receivable — — — — — — — —
Inventory $584.0K — — — — — — —
Total Current Assets $79.8M $5.8M $7.9M $8.8M $15.9M $25.3M $35.9M $5.8M
Property, Plant & Equipment $93.0K $80.0K $146.0K $221.0K $244.0K $251.0K $228.0K $259.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $81.5M $6.0M $8.3M $9.5M $16.8M $26.3M $37.1M $6.1M
Liabilities
Accounts Payable $511.0K $165.0K $357.0K $116.0K $279.0K $275.0K $284.0K $630.0K
Total Current Liabilities $3.4M $2.5M $3.8M $2.1M $2.0M $1.3M $4.8M $4.8M
Long-Term Debt — — — — — — — —
Total Liabilities $4.0M $2.5M $3.8M $2.2M $2.4M $2.0M $5.6M $4.8M
Stockholders' Equity
Retained Earnings $-104.1M $-90.9M $-79.5M $-68.8M $-55.6M $-44.3M $-35.1M $-27.9M
Total Stockholders' Equity $77.6M $3.5M $4.5M $7.3M $14.4M $24.3M $31.5M $1.3M
← Newer Page 1 of 2 Older →